Observational study on the relationship between meal intake and postprandial blood glucose level

Observational study on the relationship between meal intake and postprandial blood glucose level - Observational study on the relationship between meal intake and postprandial blood glucose level

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052138

Enrollment

Registered

2024-03-31

Start date

2023-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

borderline diabetics

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Japanese male and female between 20 and 70 years of age. 2. Whoes BMI is between 18 and 30. 2. Borderline diabetics or fasting blood glucose level is 110 mg/dL to 125 mg/dL or HbA1c level is 6.0% to 6.4% 3. Subjects who are able to submit the written informed consents.

Exclusion criteria

Exclusion criteria: 1. Subjects who consume probiotic foods or prebiotic foods during the study period 2. Subjects taking antibiotics 3. Subjects with a history of diabetes in the past 4. Subjects useing a cardiac pacemaker 5. Subjects with food allergies, or vegetarians 6. Subjects who cannot cook 7. Subjects execising hard or doing heavy physical labor during the study period 8. Subjects who undergo CT, MRT, and X-ray examinations during the study period 9. Subjects who will be underwater for more than 30 minutes during the study period 10. Subjects who cannot use measuring equipments 11. Subjects who have a history of drug dependence or alcohol dependence 12. Subjects in ohther clinical trial 13. Subjects who are pregnant, planning to become pregnant, or lactating 14. Subjects who are deemed to be unsuitable by the investigator.

Design outcomes

Primary

Measure	Time frame
the postprandial blood glucose level	—

Countries

Japan

Contacts

Public ContactTakayoshi Machida

Ezaki Glico Co., Ltd Health Innovation Business Headquarter

takayoshi.machida@glico.com080-8932-0881

Outcome results